Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

224.7200 USD 2.8500 1.25%

As of 16:15:06 ET on 03/06/2015.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 227.5000 High - Low: 227.5000 - 222.4094 Primary Exchange: NYSE Arca
Volume: 976,281 52-Week Range: 115.3117 - 229.1800 Beta vs SPSIBITR: 0.9989

ETF Chart for XBI

No chart data available.
  • XBI:US 224.7200
  • 1D
  • 1M
  • 1Y
227.5700
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2015-03-05) 227.5017
Assets (M) (on 2015-03-05) 2,184.0160
Shares out (M) 9.60
Market Cap (M) 2,157.31
% Premium 0.03
Average 52-Week % Premium -0.0029
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-19) 0.4910
Dividend Yield (ttm) 0.89%

Performance for XBI

1-Month +15.21% 1-Year +38.08%
3-Month +25.86% 3-Year +44.81%
Year To Date +22.05% 5-Year +31.39%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 03/05/2015
Name Position Value % of Total
Exelixis Inc 15,284,793 47,535,706 2.178%
Foundation Medicine Inc 911,673 42,821,281 1.962%
Halozyme Therapeutics Inc 2,678,144 41,216,636 1.888%
Pharmacyclics Inc 161,311 41,008,482 1.879%
Intercept Pharmaceuticals Inc 155,454 40,601,476 1.860%
Neurocrine Biosciences Inc 973,996 39,855,916 1.826%
Intrexon Corp 792,208 39,214,296 1.797%
OPKO Health Inc 2,616,012 37,461,292 1.716%
Celldex Therapeutics Inc 1,186,856 35,344,572 1.619%
ZIOPHARM Oncology Inc 2,438,999 33,682,576 1.543%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil